William Fangman, MD
MOHS-Micrographic Surgery · Gastonia, NCNPI 1851404859
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 28.2% of the total.
Across 72 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$436
- Integra Lifesciences Corporation$137
- Genentech USA, Inc.$120
- Sun Pharmaceutical Industries Inc.$85
- Organogenesis Inc.$85
- Mentor Worldwide LLC$73
- plus $614 from 18 others
What the payments were for
- Food & beverage$1,549100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $436 |
| Integra Lifesciences Corporation | 6 | $137 |
| Genentech USA, Inc. | 7 | $120 |
| Sun Pharmaceutical Industries Inc. | 6 | $85 |
| Organogenesis Inc. | 4 | $85 |
| Mentor Worldwide LLC | 2 | $73 |
| Pfizer | 1 | $71 |
| UCB, Inc. | 2 | $62 |
| Novartis | 3 | $59 |
| Incyte Corporation | 3 | $49 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $48 |
| Tempus AI, Inc | 2 | $48 |
| Solventum Corporation | 1 | $39 |
| Lilly USA, LLC | 2 | $35 |
| LEO Pharma Inc. | 1 | $26 |
| Sanofi | 1 | $25 |
| Mimedx Group, Inc. | 1 | $25 |
| Vertex | 1 | $22 |
| Smith+Nephew | 1 | $22 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Almirall LLC | 1 | $21 |
| Medtronic | 1 | $14 |
| DUSA Pharmaceuticals, Inc. | 1 | $14 |
| Strata Skin Sciences, Inc. | 1 | $13 |
How this compares
$1,549 in reported general payments places this provider in the 55th percentile of 50 mohs-micrographic surgery providers in North Carolina.
See all mohs-micrographic surgery providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 20 | $1,614 |
| Mupirocin | 111 | $700 |
| Doxycycline Monohydrate | 44 | $396 |
| Triamcinolone Acetonide | 11 | $96 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Gastonia
- Parteek SinglaGastonia$2K
- Girish MunavalliCharlotte$118K
- Eric ChallgrenRaleigh$47K
- Laura RosenzweigCharlotte$27K
- David LaneCharlotte$14K
- Timothy FlynnCary$12K
- Gregory WilmothRaleigh$8K
- Randall ProctorGreenville$6K
- Steffany ShearerRaleigh$5K
- Sasha HaberleCharlotte$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.